These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 34219730)
21. Knockout of 5-lipoxygenase prevents dexamethasone-induced tau pathology in 3xTg mice. Joshi YB; Chu J; Praticò D Aging Cell; 2013 Aug; 12(4):706-11. PubMed ID: 23634895 [TBL] [Abstract][Full Text] [Related]
22. Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice. Stojakovic A; Chang SY; Nesbitt J; Pichurin NP; Ostroot MA; Aikawa T; Kanekiyo T; Trushina E J Alzheimers Dis; 2021; 79(1):335-353. PubMed ID: 33285637 [TBL] [Abstract][Full Text] [Related]
23. Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease. Ye C; Liang Y; Chen Y; Xiong Y; She Y; Zhong X; Chen H; Huang M Cells; 2021 May; 10(5):. PubMed ID: 34064687 [TBL] [Abstract][Full Text] [Related]
24. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease. Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984 [TBL] [Abstract][Full Text] [Related]
25. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814 [TBL] [Abstract][Full Text] [Related]
27. Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology. Jiang XW; Liu WW; Wu YT; Wu Q; Lu HY; Xu ZH; Gao HY; Zhao QC J Ethnopharmacol; 2020 Mar; 249():112433. PubMed ID: 31783135 [TBL] [Abstract][Full Text] [Related]
28. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model. Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967 [TBL] [Abstract][Full Text] [Related]
29. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. Rockenstein E; Torrance M; Adame A; Mante M; Bar-on P; Rose JB; Crews L; Masliah E J Neurosci; 2007 Feb; 27(8):1981-91. PubMed ID: 17314294 [TBL] [Abstract][Full Text] [Related]
30. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition. Baglietto-Vargas D; Kitazawa M; Le EJ; Estrada-Hernandez T; Rodriguez-Ortiz CJ; Medeiros R; Green KN; LaFerla FM Neurobiol Dis; 2014 Feb; 62():407-15. PubMed ID: 24176788 [TBL] [Abstract][Full Text] [Related]
31. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease. Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247 [TBL] [Abstract][Full Text] [Related]
34. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice. Tapia-Rojas C; Inestrosa NC J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990 [TBL] [Abstract][Full Text] [Related]
35. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease. Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868 [TBL] [Abstract][Full Text] [Related]
36. Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice. Belfiore R; Rodin A; Ferreira E; Velazquez R; Branca C; Caccamo A; Oddo S Aging Cell; 2019 Feb; 18(1):e12873. PubMed ID: 30488653 [TBL] [Abstract][Full Text] [Related]
37. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse. Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470 [TBL] [Abstract][Full Text] [Related]
38. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model. Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551 [TBL] [Abstract][Full Text] [Related]
39. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A; Xu X; Bi X; Baudry M J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441 [TBL] [Abstract][Full Text] [Related]
40. [Chronic sleep deprivation exacerbates cognitive and pathological impairments in APP/PS1/tau triple transgenic Alzheimer's disease model mice]. Wang C; Cao X; Yin J; Gao WR; Li WR; Qi JS; Wu MN Sheng Li Xue Bao; 2021 Jun; 73(3):471-481. PubMed ID: 34230948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]